Comparing Two Doses of Ipilimumab

Publication
Article
Special ReportsMelanoma (Issue 4)
Volume 4
Issue 1

Ahmad Tarhini, MD, PhD, associate professor, University of Pittsburgh School of Medicine, compares two doses of ipilimumab (Yervoy).

Ahmad Tarhini, MD, PhD, associate professor, University of Pittsburgh School of Medicine, compares two doses of ipilimumab (Yervoy).

<<<

Back to the Melanoma Special Report

Newsletter

Stay up to date on practice-changing data in community practice.

Recent Videos